1109276-87-0

Basic information

• Product Name: Methyl 2-((1r,4r)-4-(4-(4-chloro-5-oxo-7,8-dihydropyriMido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl)cyclohexyl)acetate
• Synonyms: Methyl {trans-4-[4-(4-aMino-5-oxo-7,8-dihydropyriMido[5,4-f][1,4]oxazepin-6-(5H)-yl)phenyl]cyclohexyl}acetate;Methyl 2-((1r,4r)-4-(4-(4-chloro-5-oxo-7,8-dihydropyriMido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl)cyclohexyl)acetate;Cyclohexaneacetic acid, 4-[4-(4-aMino-7,8-dihydro-5-oxopyriMido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl]-, Methyl ester, trans-;trans-4-[4-(4-aMino-5-oxo-7,8-dihydropyriMido[5,4-f][1,4]oxazepin-6-(5H)-yl)phenyl]cyclohexyl}acetate;VREDYRHKGZWDKN-SHTZXODSSA-N
• CAS NO: 1109276-87-0
• Molecular Formula: C₂₂H₂₆N₄O₄
• Molecular Weight: 429.89666
• Mol File: 1109276-87-0.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Methyl 2-((1r,4r)-4-(4-(4-chloro-5-oxo-7,8-dihydropyriMido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl)cyclohexyl)acetate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 2-((1r,4r)-4-(4-(4-chloro-5-oxo-7,8-dihydropyriMido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl)cyclohexyl)acetate(1109276-87-0)
• EPA Substance Registry System: Methyl 2-((1r,4r)-4-(4-(4-chloro-5-oxo-7,8-dihydropyriMido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl)cyclohexyl)acetate(1109276-87-0)

Safety Data

• Hazardous Substances Data: 1109276-87-0(Hazardous Substances Data)

Upstream product

• 1109277-49-7 methyl {trans-4-[4-(4-chloro-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6-(5H)-yl)phenyl]cyclohexyl}acetate 

Downstream Products

• 1109276-89-2 2-((1r,4r)-4-(4-(4-amino-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl)cyclohexyl)acetic acid 
• 1236356-03-8 4-amino-6-{4-[trans-4-(2-amino-2-methylpropyl)cyclohexyl]phenyl}-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-5(6H)-one 
• 1450727-63-5 2-{trans-4-[4-(4-amino-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl]cyclohexyl}ethanol 
• 1236356-01-6 4-amino-6-{4-[trans-4-(2-hydroxy-2-methylpropyl)cyclohexyl]phenyl}-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-5(6H)-one 

Relevant articles and documents

Discovery of PF-04620110, a potent, selective, and orally bioavailable inhibitor of DGAT-1

Acyl-CoA:diacylglycerol acyltransferase-1 (DGAT-1) catalyzes the final committed step in the biosynthesis of triglycerides. DGAT-1 knockout mice have been shown to be resistant to diet-induced obesity and have increased insulin sensitivity. Thus, inhibiti

SUBSTITUTED BICYCLOLACTAM COMPOUNDS

The invention provides compounds of formula (1), and the pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5a, R5b, R5c, R5d, Q, A, Z, and R7 /s